Compare RNXT & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNXT | ABLV |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.4M | 39.9M |
| IPO Year | 2021 | 2022 |
| Metric | RNXT | ABLV |
|---|---|---|
| Price | $1.42 | $0.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.25 | N/A |
| AVG Volume (30 Days) | ★ 317.3K | 34.4K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,123,000.00 | N/A |
| Revenue This Year | $194.66 | N/A |
| Revenue Next Year | $279.78 | N/A |
| P/E Ratio | ★ N/A | $16.70 |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $0.54 |
| 52 Week High | $1.45 | $1.77 |
| Indicator | RNXT | ABLV |
|---|---|---|
| Relative Strength Index (RSI) | 79.87 | 29.11 |
| Support Level | $0.82 | $0.59 |
| Resistance Level | N/A | $0.73 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 98.25 | 13.21 |
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.